MedTrace Logo

Fetal Myocardial Performance Index in Diabetic Pregnancies

NCT03925064 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2019-12-10

No results posted yet for this study

Summary

The myocardial tissue is the most likely structure affected by hyperglycemia. The myocardial performance index (MPI) is a pulsed wave Doppler-derived index of global myocardial function. It is defined as the sum of the isovolumetric contraction time (ICT) and isovolumetric relaxation time (IRT) divided by the ejection time (ET) The fetal right heart contributes more to the cardiac output than the left heart; therefore, it is important to assess the right ventricular function. The investigators will measure right ventricular MPI in diabetic and normal pregnancies.

Conditions

  • Gestational Diabetes
  • Myocardial Dysfunction

Interventions

OTHER

myocardial performance index

fetal right ventricular myocardial performance index measured with tissue doppler

Sponsors & Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03925064 on ClinicalTrials.gov